Joel Isaacson & Co., LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 109 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Joel Isaacson & Co., LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$57,000
+42.5%
9,0000.0%0.01%
+37.5%
Q3 2016$40,000
+53.8%
9,0000.0%0.01%
+33.3%
Q2 2016$26,000
+4.0%
9,0000.0%0.01%0.0%
Q1 2016$25,000
-73.1%
9,0000.0%0.01%
-73.9%
Q4 2015$93,000
-9.7%
9,0000.0%0.02%
-14.8%
Q3 2015$103,000
-42.5%
9,000
-25.0%
0.03%
-41.3%
Q2 2015$179,000
+65.7%
12,0000.0%0.05%
+70.4%
Q1 2015$108,000
-26.0%
12,0000.0%0.03%
-30.8%
Q4 2014$146,000
+24.8%
12,0000.0%0.04%
+8.3%
Q3 2014$117,000
-23.5%
12,0000.0%0.04%
-25.0%
Q2 2014$153,000
+20.5%
12,0000.0%0.05%
+11.6%
Q1 2014$127,000
+39.6%
12,0000.0%0.04%
+30.3%
Q4 2013$91,000
+4.6%
12,0000.0%0.03%
-8.3%
Q3 2013$87,000
+357.9%
12,0000.0%0.04%
+300.0%
Q2 2013$19,000
+35.7%
12,0000.0%0.01%
+28.6%
Q1 2013$14,000
-17.6%
12,0000.0%0.01%
-36.4%
Q4 2012$17,00012,0000.01%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
DG Capital Management, LLC 1,186,726$4,076,0002.45%
Sarissa Capital Management LP 4,861,000$16,697,0001.97%
Ghost Tree Capital, LLC 1,950,000$6,698,0001.94%
ORACLE INVESTMENT MANAGEMENT INC 2,525,857$8,676,0001.14%
Eversept Partners, LP 1,143,211$3,926,9300.87%
DAFNA Capital Management LLC 749,051$2,573,0000.84%
KNOTT DAVID M 397,361$1,365,0000.80%
Parkman Healthcare Partners LLC 800,740$2,751,0000.73%
ACUTA CAPITAL PARTNERS, LLC 660,000$2,267,0000.62%
Formidable Asset Management, LLC 578,200$1,949,0000.57%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders